Governance ICON Public Limited Company

ICLR

IE0005711209

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 20:16:54 22/01/2026 GMT			5-day change	1st Jan Change
186.32 ^USD	+0.78%		+1.70%	+1.89%

01-08	Peace Was Cheaper
01-08	Truist Downgrades ICON PLC to Hold From Buy, Trims Price Target to $222 From $231	MT

Executive Committee: ICON Public Limited Company

Manager

Positions heldSince

Nigel Bernard John Clerkin

53 year

Director of Finance/CFO

30/09/2024

Kate Haven

Investor Relations Contact

Joe Cronin

Human Resources Officer

31/12/2013

Tom O'Leary

Chief Tech/Sci/R&D Officer

Diarmaid Cunningham

51 year

Chief Administrative Officer	30/06/2016
General Counsel	31/10/2009
Corporate Secretary	-

Simon Holmes

Chief Investment Officer

Composition of the Board of Directors: ICON Public Limited Company

Director

CommitteesSince

Ciaran Murray

63 year

Chairman	28/02/2017
Independent Dir/Board Member	30/04/2018

Linda Grais

68 year

Audit Committee	27/01/2019
Governance Committee	30/06/2021
Nominating Committee	30/06/2021
Compensation Committee	30/06/2021
Organization Committee	30/06/2021

Julie O'Neill

59 year

Compensation Committee Chair	29/08/2024
Audit Committee	02/05/2021
Audit Committee Chair	31/08/2022
Compensation Committee	22/07/2019
Organization Committee	22/07/2019

Rónán Murphy

68 year

Executive Committee	17/10/2016
Compensation Committee	17/10/2016
Organization Committee	17/10/2016
Audit Committee Chair	18/02/2019

Eugene McCague

67 year

Audit Committee	03/10/2017
Governance Committee Chair	03/10/2017
Nominating Committee Chair	03/10/2017

Anne Michelle Whitaker

58 year

Governance Committee	22/07/2024
Nominating Committee	22/07/2024

Stephen Cutler

65 year

Executive Committee

24/11/2015

John Climax

73 year

Director/Board Member	31/12/2009
Independent Dir/Board Member	31/12/2009

Latest Appointments: ICON Public Limited Company

04/09/25	ICON plc Announces CEO Changes, Effective October 1, 2025	CI
04/09/25	ICON plc Appoints Barry Balfe to the Board	CI
04/09/25	Icon Promotes COO Barry Balfe to CEO Role	MT
02/09/25	IQVIA names Michael Fedock as financial chief	RE
03/04/25	Telix Pharmaceuticals Limited Announces Appointment of Anne Whitaker as A Non-Executive Director Based in the United States, Effective 7 April 2025	CI
18/12/24	ICON Names Barry Balfe Chief Operating Officer	MT
18/12/24	ICON plc Announces Appointment of Barry Balfe as Chief Operating Officer	CI

More news

Former Officers and Directors: ICON Public Limited Company

Insider

Positions held

SinceUntil

Paul McCracken

Corporate Officer/Principal

13/10/2016

01/11/2024

Brendan Brennan

Director of Finance/CFO	31/01/2012	30/09/2024
Investor Relations Contact	-	30/09/2024
Corporate Officer/Principal	31/01/2011	31/01/2012

Joan Garahy

Director/Board Member	19/11/2017	22/07/2024
Independent Dir/Board Member	19/11/2017	22/07/2024

Tami Klerr-Naivar

Corporate Officer/Principal

01/12/2023

Colin Shannon

Director/Board Member

31/12/2009

30/12/2022

Nuala Murphy

Corporate Officer/Principal

25/08/2012

31/08/2022

Hugh Brady

Director/Board Member	29/04/2014	25/07/2022
Independent Dir/Board Member	29/04/2014	25/07/2022

Mary K. Pendergast

Director/Board Member	19/02/2014	25/07/2022
Independent Dir/Board Member	19/02/2014	25/07/2022

William Walmsley Hall

Director/Board Member	20/02/2013	25/07/2022
Independent Dir/Board Member	20/02/2013	25/07/2022

Gregory Licholai

Chief Tech/Sci/R&D Officer

31/10/2021

Kristen Buck

Chief Tech/Sci/R&D Officer

29/02/2020

30/06/2021

Haichen Yang

Private Equity Investor

29/02/2016

31/05/2021

Neil McCullough

Compliance Officer	-	30/09/2020
Corporate Officer/Principal	-	22/03/2015

Anthony Japour

Chief Tech/Sci/R&D Officer

31/01/2016

31/03/2020

Dermot Kelleher

Director/Board Member	30/04/2008	24/07/2019
Independent Dir/Board Member	30/04/2008	24/07/2019

Declan McKeon

Director/Board Member	31/03/2010	24/07/2019
Chairman	30/03/2016	28/02/2017
Independent Dir/Board Member	31/03/2010	31/12/2018

Jin Jin Liang

Corporate Officer/Principal

31/08/2017

30/06/2019

Ronan Lambe

Director/Board Member	31/12/2007	23/07/2018
Chairman	31/05/1990	31/10/2002
Founder	31/05/1990	23/07/2018
Independent Dir/Board Member	31/05/1990	23/07/2018

Julie Ryan

Corporate Officer/Principal

31/12/2014

31/12/2017

Brendan Buckley

Chief Tech/Sci/R&D Officer

11/07/2013

31/03/2017

Dominic Smethurst

Corporate Officer/Principal

30/06/2015

31/08/2016

Thomas Gerard Lynch

Director/Board Member	30/03/2016	21/07/2016
Chairman	27/01/2013	30/03/2016
Independent Dir/Board Member	31/07/1994	30/03/2016

Sandra Mumanachit

Private Equity Analyst

31/07/2012

30/09/2014

Ira Spector

Corporate Officer/Principal

09/09/2014

Michael McGrath

Chief Tech/Sci/R&D Officer

31/01/2014

Cathrin Petty

Director/Board Member	26/10/2010	23/01/2014
Independent Dir/Board Member	08/06/2011	23/01/2014

Eric Humes

Corporate Officer/Principal

31/12/2008

31/12/2013

Kimberly Ma

Corporate Officer/Principal

31/12/2010

31/12/2013

Robert L. Howie

Sales & Marketing

15/01/2013

Bruce Given

Director/Board Member	31/08/2004	06/01/2010
Chairman	06/01/2010	31/12/2012
Independent Dir/Board Member	31/08/2004	06/01/2010

Peter Gray

Director/Board Member	08/06/2011	18/07/2012
Chief Executive Officer	31/10/2002	31/08/2011
Chief Operating Officer	31/05/2001	31/10/2002
Director of Finance/CFO	31/05/1997	31/05/2001

Alan Morgan

Chief Tech/Sci/R&D Officer	15/06/2011	-
Corporate Officer/Principal	08/06/2011	15/06/2011

Donald Kraft

Human Resources Officer	31/12/2011	31/12/2015
Corporate Officer/Principal	31/12/2015	-

George A. McMillan

Corporate Officer/Principal

31/12/2011

Anthony John Murphy

Director/Board Member	26/04/2009	30/12/2011
Independent Dir/Board Member	08/06/2011	30/12/2011

Nathalie Riebel

Chief Tech/Sci/R&D Officer

30/11/2001

28/02/2011

William P. Taaffe

Founder	-	31/12/2010
Corporate Officer/Principal	-	31/12/2010

Edward Roberts

Director/Board Member	31/01/1998	18/04/2010
Director/Board Member	-	-

Shuji Higuchi

Director/Board Member

23/04/2009

Richard Bryce

Chief Tech/Sci/R&D Officer

31/07/2007

31/08/2008

David Young

Corporate Officer/Principal

31/08/2003

Sian Bigora

General Counsel

31/12/2004

31/12/2005

Markus H. Weissbach

Corporate Officer/Principal

31/12/1995

31/12/2002

Elizabeth Thiele

Corporate Officer/Principal

31/12/2001

Eimear Kenny

Human Resources Officer

23/09/2009

Josephine Coyle

Corporate Officer/Principal

31/07/1992

Alice Lioi

Corporate Officer/Principal

Daniel White

Chief Operating Officer

Lee Jones

Director/Board Member

David Hinds

Corporate Officer/Principal

Stephen Toon

Corporate Officer/Principal

Jan Skoumal

Chief Tech/Sci/R&D Officer

Jonathan Curtain

Corporate Officer/Principal

Gillian Greer

Director/Board Member

John Hubbard

Corporate Officer/Principal

31/12/2009

Sam Farthing

Public Communications Contact

06/04/2011

Mark A. Quigley

Compliance Officer	10/05/2012	-
General Counsel	08/06/2011	10/05/2012

Kent Thoelke

Corporate Officer/Principal

Niamh Murphy

Public Communications Contact

Deirdre Murphy

Public Communications Contact

23/09/2009

Emily Brand

Public Communications Contact	-	-
Corporate Officer/Principal	06/04/2011	15/06/2011

Age distribution of managers

Parity Men Women

Male	14
Female	4

Of which Executive Committee

Male	5
Female	1

Of which Directors

Male	6
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Employees

39,800

Sector

Biotechnology & Medical Research

Calendar

02-24 - Q4 2025 Earnings Release (Projected)

More about the company